Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-06-07
2005-06-07
Nguyen, Dave T. (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100, C435S455000, C435S325000
Reexamination Certificate
active
06903077
ABSTRACT:
The invention relates to products and methods for delivering nucleic acids of various sizes and preferably greater than 50 kilobases into cells. The nucleic acids are delivered as part of a nucleic acid delivery complex which is composed of at least a nucleic acid binding and condensation domain.
REFERENCES:
patent: 5217864 (1993-06-01), Heintz et al.
patent: 5504192 (1996-04-01), Gill et al.
patent: 5661025 (1997-08-01), Szoka, Jr. et al.
patent: 5721118 (1998-02-01), Scheffler
patent: 5770222 (1998-06-01), Unger et al.
patent: 5830880 (1998-11-01), Sedlacek et al.
patent: 5863737 (1999-01-01), Maki et al.
patent: 5976567 (1999-11-01), Wheeler et al.
patent: 6130313 (2000-10-01), Li et al.
patent: WO 92/03479 (1992-05-01), None
patent: WO 94/23751 (1994-10-01), None
patent: WO 96/13599 (1996-05-01), None
patent: WO 96/36362 (1996-11-01), None
patent: 96-40958 (1996-12-01), None
patent: 96-40961 (1996-12-01), None
patent: WO 97/46100 (1997-12-01), None
patent: WO 98/22140 (1998-05-01), None
Chiu et al., Optimizing energy potentials for success in protein tertiary structure prediction, May 7, 1998, Folding & Design, vol. 3, pp. 223-228.
Wells et al., The chemokine information source: identification and characterization of novel chemokines using the WorldWideWed and Expessed Sequence Tag Databases, May 1997, Journal of Leukocyte Biology, vol. 61, pp. 545-550.
Gerhold et al., It's the genes! EST access to human genome content, Oct. 18, 1996, BioEssays, vol. 18, No. 12, pp. 973-981.
Russell et al., Structual Features can be Unconserved in Proteins with Similar Fold, 1994, J. Mol. Biol., vol. 244, pp. 332-350.
Dunlap et al., Nanoscopic structure of DNA condensed for gene delivery, 1997, Nucleic Acids Research, vol. 25, No. 15, pp. 3095-3101.
Barker et al., Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirou carrier, 1997, Nucleic Acid Research, vol. 25, No. 10, pp. 1950-1956.
Marschall et al., Transfer of YACs up to 2.3 Mb intact in human cells with polyethylenimine, 1996, Gene Therapy, vol. 6, pp. 1634-1637.
Verma et al., Gene therapy-promises, problems and prospects, Sep. 18, 1997, Nature, vol. 389, pp. 239-242.
Ngo et al., Computational Complexity Protein Structure Prediction, and the Levinthal Paradox, 1994, Birkhauser Boston, vol. 14, pp. 492-495.
Brahcn, A good antisense molecule is hard to find, Feb. 1998, Elsecier Science Ltd., TIBS, vol. 23, pp. 45-50.
Anderson, Human gene therapy, Apr. 30, 1998, Nature, vol. 392, pp. 25-30.
The Sanger Centre, et al. (Genome Research, vol. 8 No. 11, 1998, pp. 1097-1108).
GenBank Accession No. AC 005586, Sep. 2000.
Boulikas, et al., “Histones, Protamine and Polylysine But Not Poly(E:K) Enhance Transfection Efficiency”Int'l J. Oncol.,10:2, pp. 317-322 (1997).
Yang, et al., “Homologous recombination based modification inEscherichia coliand germline transmission in transgenic mice of a bacterial artificial chromosome”Nature Biotechnology,vol. 15, pp. 859-865 (1997).
Houchens, et al., “The dhrf ori-beta-binding protein RIP60 contains 15 zinc fingers: DNA binding and looping by the central three fingers and an associated proline-rich region”Nucleic Acid Res.,28:2, pp. 570-581 (2000).
Wels, et al., “Biotechnological and gene therapeutic strategies in cancer treatment”,Gene,159(1):73-80 (1995) (Abstract).
Cooper, M.J., “Noninfectious gene transfer and expression systems for cancer gene therapy”,Semin. Oncol.,23(1):172-87 (1996) (Abstract).
Cristiano, R.J., “Targeted, non-viral gene delivery for cancer gene therapy”,Front Biosci,3:D116-70 (1998) (Abstract).
Harris, et al., “Receptor-mediated gene transfer to airway epithelial cells in primary culture”,Am. J. Respir. Cell Mol. Biol.,9(4):441-7 (1993) (Abstract).
wolfert, et al., “Chloroquine and amphipathic peptide helices show synergistic transfection in vitro”,Gene Ther.,5(3):409-14 (1998) (Abstract).
Baker, et al., “Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery”,Gene Ther.,4(8):773-82 (1997) (Abstract).
Perales, et al., “An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes”,Eur. J. Biochem.,226(2):255-66 (1994) (Abstract).
Miller, et al, “Targeted vectors for gene therapy”,FASEB J.,9(2):190-9 (1995) (Abstract).
Perales, et al., “Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake”,Proc. Natl. Acad. Sci.USA, 91(9):4086-90 (1994) (Abstract).
Schaffer, et al., “Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery”,J. Biol. Chem.,273(43):28004-8 (1998) (Abstract).
Kim, et al., “Getting a handhold on DNA: Design of poly-zinc finger proteins with femtomolar dissociation constants”,Proc. Natl. Acad. Sci.USA 95(6):2812-7 (1998) (Abstract).
Liu, et al., “Design of polydactyl zinc-finger proteins for unique addressing within complex genomes”,Proc. Natl. Acad. Sci.USA, 94(11):5525-30 (1997) (Abstract).
Wu, et al., “Building zinc fingers by selection: toward a therapeutic application”,Proc. Natl. Acad.USA, 92(2):344-8 (1995) (Abstract).
Schwarzenberger, et al., “Targeted gene transfer for human hematopoietic progenitor cell lines through the c-kit receptor”,Blood,87(2):472-8 (1996) (Abstract).
Buschle, et al., “Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex”,Hum. Gene Ther.,6(6):753-61 (1995) (Abstract).
Fisher, et al., “Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer”,Biochem. J.,299 (Pt. 1):49-58 (1994) (Abstract).
Thurnher, et al., “Carbohydrate receptor-mediated gene transfer to human T leukaemic cells”,Glycobiology,4(4):429-35 (1994) (Abstract).
Mahato, et al., “Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations”,Crit. Rev. Ther. Carrier Syst.,14(2):133-72 (1997) (Abstract).
Leong, et al., “DNA-polycation nanospheres as non-viral gene delivery vehicles”,J. Controlled Release,53(1-3):183-93 (1998) (Abstract).
Carpenter, et al., “Targeting of a cholecystokinin-DNA complex to pancreatic cells in vitro and in vivo”,Gene Ther.,5(6):848-54 (1998) (Abstract).
Ding, et al., “Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells”,J. Biol. Chem.,270(8):3667-76 (1995) (Abstract).
Ferkol, et al., “Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor”,J. Clin. Invest.,95(2):493-502 (1995) (Abstract).
Simoes, et al., “Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides”,Gene Ther.,5(7):955-64 (1998) (Abstract).
Batra, et al., “Receptor-mediated gene delivery employing lectin-binding specificity”,Gene Ther.,1(4):255-60 (1994) (Abstract).
Phillips, S.C., “Receptor-mediated DNA delivery approaches to human gene therapy”,Biologicals,23(1):13-6 (1995) (Abstract).
Curiel, D.T., “High-efficiency gene transfer employing adenovirus-polylysine-DNA complexes”,Nat. Immun.,13(2-3):141-64 (1994) (Abstract).
Morris, et al., “A new peptide vector for efficient delivery of oligonucleotides into mammalian cells”,Nucleic Acids Res.,25(14):2730-6 (1997) (Abstract).
Gottschalk, et al., “A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells”,Gene Ther.,3(5):48-57 (1996) (Abstract).
Fominaya, et al., “Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system
Nguyen Dave T.
University of Vermont and State Agricultural College
Wolf Greenfield & Sacks P.C.
LandOfFree
Methods and products for delivering nucleic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and products for delivering nucleic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and products for delivering nucleic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3497367